Chimeric Antigen Receptor beyond CAR-T Cells

por Qin, Vicky Mengfei, D’Souza, Criselle, Neeson, Paul J., Zhu, Joe Jiang
Publicado 2021

Combining chemotherapy with CAR-T cell therapy in treating solid tumors

por Wang, Arthur Xuan, Ong, Xiao Jing, D’Souza, Criselle, Neeson, Paul J., Zhu, Joe Jiang
Publicado 2023

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors

por Qin, Vicky Mengfei, Haynes, Nicole M., D’Souza, Criselle, Neeson, Paul J., Zhu, Joe Jiang
Publicado 2022

CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/β-catenin pathway

por Cao, Ting, Xiao, Tian, Huang, Guanqun, Xu, Yafei, Zhu, Joe Jiang, Wang, Kaixin, Ye, Wencai, Guan, Hong, He, Jinsong, Zheng, Duo
Publicado 2017

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells

por Richardson, Kelden, Keam, Simon P., Zhu, Joe Jiang, Meyran, Deborah, D’Souza, Criselle, Macdonald, Sean, Campbell, Kerry, Robbins, Michael, Bezman, Natalie A., Todd, Kirsten, Quach, Hang, Ritchie, David S., Harrison, Simon J., Prince, H. Miles, Trapani, Joseph A., Jenkins, Misty R., Beavis, Paul A., Darcy, Phillip K., Neeson, Paul J.
Publicado 2022